These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 35004678)

  • 1. Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes.
    Deng J; Liao Y; Liu J; Liu W; Yan D
    Front Cell Dev Biol; 2021; 9():777258. PubMed ID: 35004678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics in diabetic cardiomyopathy.
    Ma X; Mei S; Wuyun Q; Zhou L; Sun D; Yan J
    Clin Epigenetics; 2024 Apr; 16(1):52. PubMed ID: 38581056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics in dilated cardiomyopathy.
    Yu J; Zeng C; Wang Y
    Curr Opin Cardiol; 2019 May; 34(3):260-269. PubMed ID: 30973397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic cardiomyopathy--fact or fiction?
    Maisch B; Alter P; Pankuweit S
    Herz; 2011 Mar; 36(2):102-15. PubMed ID: 21424347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of microRNAs in the pathogenesis of diabetic cardiomyopathy.
    Liu X; Liu S
    Biomed Rep; 2017 Feb; 6(2):140-145. PubMed ID: 28357065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal microRNAs: potential targets for the prevention and treatment of diabetic cardiomyopathy.
    Zhang T; Gao Z; Chen K
    J Cardiol; 2022 Nov; 80(5):423-431. PubMed ID: 35000826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics of methylation modifications in diabetic cardiomyopathy.
    Hao J; Liu Y
    Front Endocrinol (Lausanne); 2023; 14():1119765. PubMed ID: 37008904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics and diabetic cardiomyopathy.
    Singh GB; Sharma R; Khullar M
    Diabetes Res Clin Pract; 2011 Oct; 94(1):14-21. PubMed ID: 21696841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Mechanisms and Epigenetic Regulation in Diabetic Cardiomyopathy.
    Mittal A; Garg R; Bahl A; Khullar M
    Front Cardiovasc Med; 2021; 8():725532. PubMed ID: 34977165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting epigenetics in diabetic cardiomyopathy: Therapeutic potential of flavonoids.
    Zhou Y; Suo W; Zhang X; Yang Y; Zhao W; Li H; Ni Q
    Biomed Pharmacother; 2023 Jan; 157():114025. PubMed ID: 36399824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of epigenetics and miRNA in diabetic cardiomyopathy.
    Asrih M; Steffens S
    Cardiovasc Pathol; 2013; 22(2):117-25. PubMed ID: 22951386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies.
    Tarquini R; Pala L; Brancati S; Vannini G; De Cosmo S; Mazzoccoli G; Rotella CM
    Curr Med Chem; 2018; 25(13):1510-1524. PubMed ID: 28685679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNAs: Proverbial Genomic "Junk" or Key Epigenetic Regulators During Cardiac Fibrosis in Diabetes?
    Biswas S; Thomas AA; Chakrabarti S
    Front Cardiovasc Med; 2018; 5():28. PubMed ID: 29670886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global analysis of histone modifications and long-range chromatin interactions revealed the differential cistrome changes and novel transcriptional players in human dilated cardiomyopathy.
    Liu CF; Abnousi A; Bazeley P; Ni Y; Morley M; Moravec CS; Hu M; Tang WHW
    J Mol Cell Cardiol; 2020 Aug; 145():30-42. PubMed ID: 32533974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response.
    Kaur N; Guan Y; Raja R; Ruiz-Velasco A; Liu W
    Front Physiol; 2021; 12():694864. PubMed ID: 34234695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes.
    Khullar M; Cheema BS; Raut SK
    Front Endocrinol (Lausanne); 2017; 8():237. PubMed ID: 29085333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and prevention of diabetic cardiomyopathy.
    Chavali V; Tyagi SC; Mishra PK
    Diabetes Metab Syndr Obes; 2013; 6():151-60. PubMed ID: 23610527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-coding RNA: A Key Regulator in the Pathogenesis of Diabetic Cardiomyopathy.
    Guo Y; Feng X; Wang D; Kang X; Zhang L; Ren H; Yuan G
    Front Cardiovasc Med; 2021; 8():655598. PubMed ID: 33889601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy.
    Yue Y; Meng K; Pu Y; Zhang X
    Diabetes Res Clin Pract; 2017 Nov; 133():124-130. PubMed ID: 28934669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basics of Epigenetics and Role of Epigenetics in Diabetic Complications.
    Yamunadevi A; Pratibha R; Rajmohan M; Mahendraperumal S; Ganapathy N
    J Pharm Bioallied Sci; 2021 Jun; 13(Suppl 1):S336-S343. PubMed ID: 34447105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.